Your browser doesn't support javascript.
loading
Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.
Pérez-Peña, Javier; Alcaraz-Sanabria, Ana; Nieto-Jiménez, Cristina; Páez, Raquel; Corrales-Sánchez, Verónica; Serrano-Oviedo, Leticia; Wali, Vikram B; Patwardhan, Gauri A; Amir, Eitan; Gyorffy, Balázs; Pandiella, Atanasio; Ocaña, Alberto.
Afiliación
  • Pérez-Peña J; Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain.
  • Alcaraz-Sanabria A; Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain.
  • Nieto-Jiménez C; Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain.
  • Páez R; Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain.
  • Corrales-Sánchez V; Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain.
  • Serrano-Oviedo L; Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain.
  • Wali VB; Yale Cancer Center, Yale University, New Haven, USA.
  • Patwardhan GA; Yale Cancer Center, Yale University, New Haven, USA.
  • Amir E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
  • Gyorffy B; Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary.
  • Pandiella A; MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary.
  • Ocaña A; Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain.
Oncotarget ; 8(13): 21733-21740, 2017 Mar 28.
Article en En | MEDLINE | ID: mdl-28423514
Luminal breast tumors have been classified into A and B subgroups, with the luminal A being associated with a more favorable clinical outcome. Unfortunately, luminal A tumors do not have a universally good prognosis. We used transcriptomic analyses using public datasets to evaluate the differential expression between normal breast tissue and breast cancer, focusing on upregulated genes included in cell cycle function. Association of selected genes with relapse free survival (RFS) and overall survival (OS) was performed using the KM Plotter Online Tool (http://www.kmplot.com). Seventy-seven genes were differentially expressed between normal and malignant breast tissue. Only five genes were associated with poor RFS and OS. The mitosis-related genes GTSE1, CDCA3, FAM83D and SMC4 were associated with poor outcome specifically in Luminal A tumors. The combination of FAM83D and CDCA3 for RFS and GTSE1 alone for OS showed the better prediction for clinical outcome. CDCA3 was amplified in 3.4% of the tumors, and FAM83D and SMC4 in 2.3% and 2.2%, respectively. In conclusion, we describe a set of genes that predict detrimental outcome in Luminal A tumors. These genes may have utility for stratification in trials of antimitotic agents or cytotoxic chemotherapy, or as candidates for direct target inhibition.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Transcriptoma Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Transcriptoma Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos